Effects of a tocolytic oxytocin analogue on lipid and carbohydrate metabolism.
Gynecol Obstet Invest
; 29(2): 97-100, 1990.
Article
em En
| MEDLINE
| ID: mdl-2335316
ABSTRACT
The effect of a newly developed tocolytic oxytocin analogue, 1-deamino-2-D-Tyr(OEt)-4-Thr-8-Orn-oxytocin on lipid and carbohydrate metabolism was investigated. Oxytocin and vasopressin both stimulated lipogenesis in isolated rat adipocytes, an effect which was dose-dependently inhibited by the oxytocin analogue. In vivo, intravenous injection of 10 nmol/kg body weight of the analogue to 11 healthy subjects caused an initial, but insignificant peak after 4 min in both plasma glucose and glycerol, which thereafter remained at basal level. It is concluded that although an antagonistic effect of the analogue on vasopressin- and oxytocin-stimulated lipogenesis could be demonstrated in vitro, the effect on lipid and carbohydrate metabolism in vivo in humans is insignificant.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Vasotocina
/
Tocolíticos
/
Metabolismo dos Carboidratos
/
Metabolismo dos Lipídeos
Limite:
Adult
/
Animals
/
Female
/
Humans
/
Male
/
Pregnancy
Idioma:
En
Revista:
Gynecol Obstet Invest
Ano de publicação:
1990
Tipo de documento:
Article
País de afiliação:
Suécia